Logo image of ARHS

ARHAUS INC (ARHS) Stock Fundamental Analysis

USA - NASDAQ:ARHS - US04035M1027 - Common Stock

10.77 USD
-0.47 (-4.18%)
Last: 9/12/2025, 8:00:01 PM
10.77 USD
0 (0%)
After Hours: 9/12/2025, 8:00:01 PM
Fundamental Rating

5

ARHS gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 123 industry peers in the Specialty Retail industry. While ARHS belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. ARHS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year ARHS was profitable.
ARHS had a positive operating cash flow in the past year.
Each year in the past 5 years ARHS has been profitable.
Each year in the past 5 years ARHS had a positive operating cash flow.
ARHS Yearly Net Income VS EBIT VS OCF VS FCFARHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

ARHS's Return On Assets of 5.40% is fine compared to the rest of the industry. ARHS outperforms 72.36% of its industry peers.
With a decent Return On Equity value of 18.46%, ARHS is doing good in the industry, outperforming 79.67% of the companies in the same industry.
ARHS's Return On Invested Capital of 7.65% is fine compared to the rest of the industry. ARHS outperforms 68.29% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ARHS is above the industry average of 11.93%.
The last Return On Invested Capital (7.65%) for ARHS is well below the 3 year average (16.29%), which needs to be investigated, but indicates that ARHS had better years and this may not be a problem.
Industry RankSector Rank
ROA 5.4%
ROE 18.46%
ROIC 7.65%
ROA(3y)10.56%
ROA(5y)7.82%
ROE(3y)40.63%
ROE(5y)N/A
ROIC(3y)16.29%
ROIC(5y)17.01%
ARHS Yearly ROA, ROE, ROICARHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 100 200 300

1.3 Margins

ARHS has a Profit Margin of 5.33%. This is in the better half of the industry: ARHS outperforms 78.05% of its industry peers.
ARHS's Profit Margin has improved in the last couple of years.
ARHS has a better Operating Margin (6.76%) than 75.61% of its industry peers.
In the last couple of years the Operating Margin of ARHS has grown nicely.
The Gross Margin of ARHS (39.34%) is better than 60.98% of its industry peers.
In the last couple of years the Gross Margin of ARHS has grown nicely.
Industry RankSector Rank
OM 6.76%
PM (TTM) 5.33%
GM 39.34%
OM growth 3Y16.64%
OM growth 5Y2.23%
PM growth 3Y26.76%
PM growth 5Y18.12%
GM growth 3Y-1.61%
GM growth 5Y2.07%
ARHS Yearly Profit, Operating, Gross MarginsARHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 10 20 30 40

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ARHS is creating some value.
Compared to 1 year ago, ARHS has more shares outstanding
ARHS has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ARHS has an improved debt to assets ratio.
ARHS Yearly Shares OutstandingARHS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M
ARHS Yearly Total Debt VS Total AssetsARHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.54 indicates that ARHS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.54, ARHS is in line with its industry, outperforming 54.47% of the companies in the same industry.
ARHS has a debt to FCF ratio of 0.93. This is a very positive value and a sign of high solvency as it would only need 0.93 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 0.93, ARHS is doing good in the industry, outperforming 79.67% of the companies in the same industry.
A Debt/Equity ratio of 0.14 indicates that ARHS is not too dependend on debt financing.
ARHS's Debt to Equity ratio of 0.14 is fine compared to the rest of the industry. ARHS outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.93
Altman-Z 2.54
ROIC/WACC0.8
WACC9.53%
ARHS Yearly LT Debt VS Equity VS FCFARHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

ARHS has a Current Ratio of 1.33. This is a normal value and indicates that ARHS is financially healthy and should not expect problems in meeting its short term obligations.
ARHS has a Current ratio (1.33) which is in line with its industry peers.
ARHS has a Quick Ratio of 1.33. This is a bad value and indicates that ARHS is not financially healthy enough and could expect problems in meeting its short term obligations.
ARHS has a Quick ratio of 0.61. This is in the better half of the industry: ARHS outperforms 60.98% of its industry peers.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.61
ARHS Yearly Current Assets VS Current LiabilitesARHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The earnings per share for ARHS have decreased strongly by -20.63% in the last year.
ARHS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 43.52% yearly.
ARHS shows a small growth in Revenue. In the last year, the Revenue has grown by 4.77%.
The Revenue has been growing by 20.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-20.63%
EPS 3Y48.09%
EPS 5Y43.52%
EPS Q2Q%56.25%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y16.84%
Revenue growth 5Y20.78%
Sales Q2Q%15.7%

3.2 Future

ARHS is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.67% yearly.
The Revenue is expected to grow by 7.58% on average over the next years.
EPS Next Y-5.18%
EPS Next 2Y3.37%
EPS Next 3Y8.13%
EPS Next 5Y6.67%
Revenue Next Year6.56%
Revenue Next 2Y6.8%
Revenue Next 3Y7.28%
Revenue Next 5Y7.58%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ARHS Yearly Revenue VS EstimatesARHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B
ARHS Yearly EPS VS EstimatesARHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.54, ARHS is valued on the expensive side.
Based on the Price/Earnings ratio, ARHS is valued a bit cheaper than 71.54% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, ARHS is valued a bit cheaper.
The Price/Forward Earnings ratio is 21.00, which indicates a rather expensive current valuation of ARHS.
The rest of the industry has a similar Price/Forward Earnings ratio as ARHS.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, ARHS is valued at the same level.
Industry RankSector Rank
PE 21.54
Fwd PE 21
ARHS Price Earnings VS Forward Price EarningsARHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ARHS indicates a somewhat cheap valuation: ARHS is cheaper than 69.92% of the companies listed in the same industry.
69.11% of the companies in the same industry are more expensive than ARHS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 26.45
EV/EBITDA 7.68
ARHS Per share dataARHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

The excellent profitability rating of ARHS may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.49
EPS Next 2Y3.37%
EPS Next 3Y8.13%

0

5. Dividend

5.1 Amount

ARHS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ARHAUS INC

NASDAQ:ARHS (9/12/2025, 8:00:01 PM)

After market: 10.77 0 (0%)

10.77

-0.47 (-4.18%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners112.32%
Inst Owner Change-0.58%
Ins Owners5.31%
Ins Owner Change7.76%
Market Cap1.52B
Analysts75
Price Target12.33 (14.48%)
Short Float %8.46%
Short Ratio2.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP0.67%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)13.91%
Min EPS beat(2)-36.28%
Max EPS beat(2)64.1%
EPS beat(4)2
Avg EPS beat(4)5.84%
Min EPS beat(4)-36.28%
Max EPS beat(4)64.1%
EPS beat(8)6
Avg EPS beat(8)78.22%
EPS beat(12)10
Avg EPS beat(12)67.47%
EPS beat(16)14
Avg EPS beat(16)74.98%
Revenue beat(2)1
Avg Revenue beat(2)1.16%
Min Revenue beat(2)-3%
Max Revenue beat(2)5.32%
Revenue beat(4)1
Avg Revenue beat(4)-1.45%
Min Revenue beat(4)-4.97%
Max Revenue beat(4)5.32%
Revenue beat(8)4
Avg Revenue beat(8)0.22%
Revenue beat(12)6
Avg Revenue beat(12)0.02%
Revenue beat(16)9
Avg Revenue beat(16)1.87%
PT rev (1m)22.36%
PT rev (3m)22.36%
EPS NQ rev (1m)5.84%
EPS NQ rev (3m)12.27%
EPS NY rev (1m)8.91%
EPS NY rev (3m)8.3%
Revenue NQ rev (1m)0.12%
Revenue NQ rev (3m)1.32%
Revenue NY rev (1m)1.4%
Revenue NY rev (3m)1.4%
Valuation
Industry RankSector Rank
PE 21.54
Fwd PE 21
P/S 1.14
P/FCF 26.45
P/OCF 10.53
P/B 3.94
P/tB 4.05
EV/EBITDA 7.68
EPS(TTM)0.5
EY4.64%
EPS(NY)0.51
Fwd EY4.76%
FCF(TTM)0.41
FCFY3.78%
OCF(TTM)1.02
OCFY9.5%
SpS9.48
BVpS2.74
TBVpS2.66
PEG (NY)N/A
PEG (5Y)0.49
Profitability
Industry RankSector Rank
ROA 5.4%
ROE 18.46%
ROCE 10.23%
ROIC 7.65%
ROICexc 10.42%
ROICexgc 10.6%
OM 6.76%
PM (TTM) 5.33%
GM 39.34%
FCFM 4.3%
ROA(3y)10.56%
ROA(5y)7.82%
ROE(3y)40.63%
ROE(5y)N/A
ROIC(3y)16.29%
ROIC(5y)17.01%
ROICexc(3y)22.28%
ROICexc(5y)30.4%
ROICexgc(3y)22.81%
ROICexgc(5y)34.8%
ROCE(3y)21.77%
ROCE(5y)22.73%
ROICexcg growth 3Y-40.08%
ROICexcg growth 5Y-10.67%
ROICexc growth 3Y-36.41%
ROICexc growth 5Y-9.4%
OM growth 3Y16.64%
OM growth 5Y2.23%
PM growth 3Y26.76%
PM growth 5Y18.12%
GM growth 3Y-1.61%
GM growth 5Y2.07%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 0.93
Debt/EBITDA 0.3
Cap/Depr 103.79%
Cap/Sales 6.5%
Interest Coverage 17.93
Cash Conversion 82.88%
Profit Quality 80.66%
Current Ratio 1.33
Quick Ratio 0.61
Altman-Z 2.54
F-Score5
WACC9.53%
ROIC/WACC0.8
Cap/Depr(3y)167.27%
Cap/Depr(5y)155.74%
Cap/Sales(3y)6.66%
Cap/Sales(5y)5.71%
Profit Quality(3y)44.67%
Profit Quality(5y)347.09%
High Growth Momentum
Growth
EPS 1Y (TTM)-20.63%
EPS 3Y48.09%
EPS 5Y43.52%
EPS Q2Q%56.25%
EPS Next Y-5.18%
EPS Next 2Y3.37%
EPS Next 3Y8.13%
EPS Next 5Y6.67%
Revenue 1Y (TTM)4.77%
Revenue growth 3Y16.84%
Revenue growth 5Y20.78%
Sales Q2Q%15.7%
Revenue Next Year6.56%
Revenue Next 2Y6.8%
Revenue Next 3Y7.28%
Revenue Next 5Y7.58%
EBIT growth 1Y-19.78%
EBIT growth 3Y36.28%
EBIT growth 5Y23.47%
EBIT Next Year61.11%
EBIT Next 3Y27.47%
EBIT Next 5Y21.19%
FCF growth 1Y90.69%
FCF growth 3Y-26.06%
FCF growth 5Y27.06%
OCF growth 1Y51.51%
OCF growth 3Y0.21%
OCF growth 5Y46.37%